About Arjun Desai
Form D filings for Pathology Watch in 2023 list Arjun Desai as director.
Arjun Desai first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Arjun Desai in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Arjun Desai works with at each company, as listed on that company's latest Form D.
Pathology Watch Inc. · Form D, Mar 7, 2023
RS
Rick Stratford
Director
SM
Scott Mattivi
Executive officer
MT
Michael Torno
Executive officer and director
AW
Austin Walters
Director
DL
Daniel Lambert
Chief Executive Officer and director